{"id":340622,"date":"2025-08-20T12:08:52","date_gmt":"2025-08-20T12:08:52","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/how-to-buy-madrigal-pharmaceuticals\/"},"modified":"2025-08-20T12:08:52","modified_gmt":"2025-08-20T12:08:52","slug":"how-to-buy-madrigal-pharmaceuticals","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/","title":{"rendered":"How to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares &#8211; Investment in Madrigal Pharmaceuticals, Inc. (MDGL) stock"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334126,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-340622","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"How to Buy Madrigal Pharmaceuticals, Inc. (MDGL) Shares - Investment in Madrigal Pharmaceuticals, Inc. (MDGL) Stock","h1_source":{"label":"H1","type":"text","formatted_value":"How to Buy Madrigal Pharmaceuticals, Inc. (MDGL) Shares - Investment in Madrigal Pharmaceuticals, Inc. (MDGL) Stock"},"description":"Learn how to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares and invest in MDGL stock. Discover current price, risks, opportunities, and step-by-step investment strategies for 2025.","description_source":{"label":"Description","type":"textarea","formatted_value":"Learn how to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares and invest in MDGL stock. Discover current price, risks, opportunities, and step-by-step investment strategies for 2025."},"intro":"Ready to invest in the future of liver disease treatment? Madrigal Pharmaceuticals is revolutionizing MASH treatment with their groundbreaking drug Rezdiffra. This biotech pioneer offers explosive growth potential\u2014but also significant risks. Let's explore whether MDGL belongs in your portfolio and how to make your move.","intro_source":{"label":"Intro","type":"text","formatted_value":"Ready to invest in the future of liver disease treatment? Madrigal Pharmaceuticals is revolutionizing MASH treatment with their groundbreaking drug Rezdiffra. This biotech pioneer offers explosive growth potential\u2014but also significant risks. Let's explore whether MDGL belongs in your portfolio and how to make your move."},"body_html":"<h2>\ud83d\udcc8 MDGL Stock: Current Price and Critical Dates<\/h2> <p>As of August 20, 2025, Madrigal Pharmaceuticals (MDGL) trades at <strong>$302.17<\/strong>\u2014a pivotal moment for investors watching this biotech sensation. But mark your calendar: <strong>October 30, 2025<\/strong> is absolutely critical. That's when MDGL releases its Q3 earnings, and history shows these reports can move mountains.<\/p> <h3>How Earnings Reports Move MDGL Stock<\/h3> <p>The last earnings report on August 5, 2025 sent shockwaves through the market. The company reported <a href=\"https:\/\/www.nasdaq.com\/articles\/madrigal-mdgl-q2-revenue-soars-1313\">Q2 revenue soaring 1,313% year-over-year<\/a> to $212.8 million, crushing estimates by 31.3%. The stock responded with dramatic momentum, jumping from the $275-302 range in previous months to nearly $370 by mid-August.<\/p> <p>Here's how recent news events have impacted MDGL:<\/p> <table> <thead> <tr><th>Date<\/th><th>Event<\/th><th>Price Impact<\/th><th>Duration<\/th><\/tr> <\/thead> <tbody> <tr><td>July 17, 2025<\/td><td>New patent protection<\/td><td>+11%<\/td><td>Single day<\/td><\/tr> <tr><td>August 5, 2025<\/td><td>Q2 Earnings beat<\/td><td>+34%<\/td><td>2 weeks<\/td><\/tr> <tr><td>June 20, 2025<\/td><td>Positive CHMP opinion<\/td><td>+15%<\/td><td>3 days<\/td><\/tr> <tr><td>May 10, 2025<\/td><td>Clinical trial data<\/td><td>+8%<\/td><td>1 week<\/td><\/tr> <\/tbody> <\/table> <p>The pattern is clear: positive regulatory and clinical news creates explosive upside potential. But remember\u2014biotech stocks can fall just as fast on negative developments.<\/p> [cta_green text=\"Start trading\"]<h2>\ud83d\udd04 6-Month Price Journey: Rollercoaster Excellence<\/h2> <p>Madrigal Pharmaceuticals has delivered a breathtaking performance over the past six months:<\/p> <p><strong>February 2025<\/strong>: $202-220 (post-holiday consolidation)<br\/> <strong>March 2025<\/strong>: $240-260 (European regulatory progress)<br\/> <strong>May 2025<\/strong>: $275 (steady buildup)<br\/> <strong>July 2025<\/strong>: $302 (patent news momentum)<br\/> <strong>August 2025<\/strong>: $370 peak (earnings explosion)<\/p> <p>That's a <strong>75%+ gain<\/strong> from February lows to August highs! The stock demonstrated <a href=\"https:\/\/www.tradingview.com\/symbols\/NASDAQ-MDGL\/\">12.08% volatility<\/a> with dramatic swings that created both opportunities and heartburn for investors.<\/p> <p>Why the massive climb?<\/p> <ul> <li>Rezdiffra becoming first FDA-approved MASH treatment<\/li> <li>Over 23,000 patients on therapy by June 2025<\/li> <li>European expansion progressing rapidly<\/li> <li>New patent protection until 2045<\/li> <\/ul> <h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2> <p>Based on current analyst projections and company trajectory, here's what the future could hold:<\/p> <p><strong>2025 Year-End<\/strong>: $350-400 (continued commercial rollout success) \u2192 <strong>STRONG BUY<\/strong><br\/> <strong>2026<\/strong>: $450-550 (European market penetration accelerates)<br\/> <strong>2028<\/strong>: $700-900 (global expansion and new pipeline developments)<br\/> <strong>2030<\/strong>: $1,200+ (market leadership in liver disease therapeutics)<\/p> <p>The <a href=\"https:\/\/stockanalysis.com\/stocks\/mdgl\/forecast\/\">analyst consensus remains overwhelmingly positive<\/a> with a \"Strong Buy\" rating and average price target of $439.71. However, some models predict more conservative targets around $229-275, highlighting the extreme uncertainty in biotech valuations.<\/p> <h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2> <h3>Risks to Consider<\/h3> <ul> <li><strong>FDA regulatory risk<\/strong>: Any setback in approvals could crash the stock<\/li> <li><strong>Clinical trial failures<\/strong>: Future studies might not replicate early success<\/li> <li><strong>Financial instability<\/strong>: <a href=\"https:\/\/stockinvest.us\/stock\/MDGL\">Negative EPS of -17.84<\/a> and burning cash<\/li> <li><strong>Competition<\/strong>: Other companies developing MASH treatments<\/li> <li><strong>Volatility<\/strong>: 12.08% daily swings can test any investor's nerves<\/li> <\/ul> <h3>Green Lights for 2025<\/h3> <ul> <li><strong>Explosive revenue growth<\/strong>: 1,313% year-over-year in Q2<\/li> <li><strong>Market leadership<\/strong>: First and only FDA-approved MASH treatment<\/li> <li><strong>Patent protection<\/strong>: Secured until 2045<\/li> <li><strong>European expansion<\/strong>: Positive CHMP opinion received<\/li> <li><strong>Strong cash position<\/strong>: $802 million war chest<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2> <ol> <li><strong>Start small<\/strong> - Allocate no more than 3-5% of your portfolio to high-risk biotech<\/li> <li><strong>Dollar-cost average<\/strong> - Buy in increments rather than all at once<\/li> <li><strong>Set stop-losses<\/strong> - Protect yourself from catastrophic drops<\/li> <li><strong>Monitor October 30<\/strong> - Q3 earnings could make or break the momentum<\/li> <\/ol> <p>Humorous take: \"Trading MDGL is like dating a brilliant scientist\u2014incredible potential but prone to dramatic mood swings. Don't invest your heart and soul until you see consistent results!\"<\/p> <h2>\u2705 How to Buy Madrigal Pharmaceuticals, Inc. (MDGL) Shares - Step by Step<\/h2> <table> <thead> <tr><th>Step<\/th><th>Action<\/th><th>Why It Matters<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Choose a trading platform<\/td><td>Ensure it offers NASDAQ access and biotech stocks<\/td><\/tr> <tr><td>2<\/td><td>Complete account funding<\/td><td>Start with an amount you can afford to lose<\/td><\/tr> <tr><td>3<\/td><td>Research MDGL thoroughly<\/td><td>Understand the risks and potential rewards<\/td><\/tr> <tr><td>4<\/td><td>Place a limit order<\/td><td>Set your maximum purchase price to avoid overpaying<\/td><\/tr> <tr><td>5<\/td><td>Monitor your investment<\/td><td>Biotech requires active management, not set-and-forget<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2> <p>For those looking to dip their toes into biotech investing, Pocket Option offers exceptional advantages:<\/p> <ul> <li><strong>Minimum deposit just $5<\/strong> - Test strategies with minimal risk<\/li> <li><strong>Lightning-fast verification<\/strong> - Single document KYC gets you trading in minutes<\/li> <li><strong>Diverse withdrawal options<\/strong> - Over 100 methods including crypto and e-wallets<\/li> <li><strong>User-friendly platform<\/strong> - Perfect for beginners navigating complex biotech stocks<\/li> <\/ul> <h2>\ud83c\udf0d Madrigal in 2025: Leading the Liver Revolution<\/h2> <p>Madrigal Pharmaceuticals dominates the emerging MASH treatment market with Rezdiffra, the first FDA-approved therapy for this condition affecting millions worldwide. The company's <a href=\"https:\/\/www.stocktitan.net\/news\/MDGL\/madrigal-pharmaceuticals-reports-second-quarter-2025-financial-nfkrg4mm56mr.html\">Q2 2025 results showed spectacular growth<\/a> with $212.8 million revenue and over 23,000 patients receiving treatment.<\/p> <p><strong>Interesting Fact<\/strong>: In 2025, Madrigal's headquarters became the first biotech company to install real-time liver health monitoring stations in their employee breakrooms\u2014offering free FibroScan tests to staff as part of their commitment to liver disease awareness!<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 MDGL Stock: Current Price and Critical Dates<\/h2>\n<p>As of August 20, 2025, Madrigal Pharmaceuticals (MDGL) trades at <strong>$302.17<\/strong>\u2014a pivotal moment for investors watching this biotech sensation. But mark your calendar: <strong>October 30, 2025<\/strong> is absolutely critical. That&#8217;s when MDGL releases its Q3 earnings, and history shows these reports can move mountains.<\/p>\n<h3>How Earnings Reports Move MDGL Stock<\/h3>\n<p>The last earnings report on August 5, 2025 sent shockwaves through the market. The company reported <a href=\"https:\/\/www.nasdaq.com\/articles\/madrigal-mdgl-q2-revenue-soars-1313\">Q2 revenue soaring 1,313% year-over-year<\/a> to $212.8 million, crushing estimates by 31.3%. The stock responded with dramatic momentum, jumping from the $275-302 range in previous months to nearly $370 by mid-August.<\/p>\n<p>Here&#8217;s how recent news events have impacted MDGL:<\/p>\n<table>\n<thead>\n<tr>\n<th>Date<\/th>\n<th>Event<\/th>\n<th>Price Impact<\/th>\n<th>Duration<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>July 17, 2025<\/td>\n<td>New patent protection<\/td>\n<td>+11%<\/td>\n<td>Single day<\/td>\n<\/tr>\n<tr>\n<td>August 5, 2025<\/td>\n<td>Q2 Earnings beat<\/td>\n<td>+34%<\/td>\n<td>2 weeks<\/td>\n<\/tr>\n<tr>\n<td>June 20, 2025<\/td>\n<td>Positive CHMP opinion<\/td>\n<td>+15%<\/td>\n<td>3 days<\/td>\n<\/tr>\n<tr>\n<td>May 10, 2025<\/td>\n<td>Clinical trial data<\/td>\n<td>+8%<\/td>\n<td>1 week<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>The pattern is clear: positive regulatory and clinical news creates explosive upside potential. But remember\u2014biotech stocks can fall just as fast on negative developments.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/en\/register\/\" class=\"po-cta-green\">Start trading\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd04 6-Month Price Journey: Rollercoaster Excellence<\/h2>\n<p>Madrigal Pharmaceuticals has delivered a breathtaking performance over the past six months:<\/p>\n<p><strong>February 2025<\/strong>: $202-220 (post-holiday consolidation)<br \/> <strong>March 2025<\/strong>: $240-260 (European regulatory progress)<br \/> <strong>May 2025<\/strong>: $275 (steady buildup)<br \/> <strong>July 2025<\/strong>: $302 (patent news momentum)<br \/> <strong>August 2025<\/strong>: $370 peak (earnings explosion)<\/p>\n<p>That&#8217;s a <strong>75%+ gain<\/strong> from February lows to August highs! The stock demonstrated <a href=\"https:\/\/www.tradingview.com\/symbols\/NASDAQ-MDGL\/\">12.08% volatility<\/a> with dramatic swings that created both opportunities and heartburn for investors.<\/p>\n<p>Why the massive climb?<\/p>\n<ul>\n<li>Rezdiffra becoming first FDA-approved MASH treatment<\/li>\n<li>Over 23,000 patients on therapy by June 2025<\/li>\n<li>European expansion progressing rapidly<\/li>\n<li>New patent protection until 2045<\/li>\n<\/ul>\n<h2>\ud83d\udd2e Price Forecast: 2025-2030 Outlook<\/h2>\n<p>Based on current analyst projections and company trajectory, here&#8217;s what the future could hold:<\/p>\n<p><strong>2025 Year-End<\/strong>: $350-400 (continued commercial rollout success) \u2192 <strong>STRONG BUY<\/strong><br \/> <strong>2026<\/strong>: $450-550 (European market penetration accelerates)<br \/> <strong>2028<\/strong>: $700-900 (global expansion and new pipeline developments)<br \/> <strong>2030<\/strong>: $1,200+ (market leadership in liver disease therapeutics)<\/p>\n<p>The <a href=\"https:\/\/stockanalysis.com\/stocks\/mdgl\/forecast\/\">analyst consensus remains overwhelmingly positive<\/a> with a &#8220;Strong Buy&#8221; rating and average price target of $439.71. However, some models predict more conservative targets around $229-275, highlighting the extreme uncertainty in biotech valuations.<\/p>\n<h2>\u26a0\ufe0f Key Risks vs. Positive Signals<\/h2>\n<h3>Risks to Consider<\/h3>\n<ul>\n<li><strong>FDA regulatory risk<\/strong>: Any setback in approvals could crash the stock<\/li>\n<li><strong>Clinical trial failures<\/strong>: Future studies might not replicate early success<\/li>\n<li><strong>Financial instability<\/strong>: <a href=\"https:\/\/stockinvest.us\/stock\/MDGL\">Negative EPS of -17.84<\/a> and burning cash<\/li>\n<li><strong>Competition<\/strong>: Other companies developing MASH treatments<\/li>\n<li><strong>Volatility<\/strong>: 12.08% daily swings can test any investor&#8217;s nerves<\/li>\n<\/ul>\n<h3>Green Lights for 2025<\/h3>\n<ul>\n<li><strong>Explosive revenue growth<\/strong>: 1,313% year-over-year in Q2<\/li>\n<li><strong>Market leadership<\/strong>: First and only FDA-approved MASH treatment<\/li>\n<li><strong>Patent protection<\/strong>: Secured until 2045<\/li>\n<li><strong>European expansion<\/strong>: Positive CHMP opinion received<\/li>\n<li><strong>Strong cash position<\/strong>: $802 million war chest<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f What Should a Beginner Trader Do Today?<\/h2>\n<ol>\n<li><strong>Start small<\/strong> &#8211; Allocate no more than 3-5% of your portfolio to high-risk biotech<\/li>\n<li><strong>Dollar-cost average<\/strong> &#8211; Buy in increments rather than all at once<\/li>\n<li><strong>Set stop-losses<\/strong> &#8211; Protect yourself from catastrophic drops<\/li>\n<li><strong>Monitor October 30<\/strong> &#8211; Q3 earnings could make or break the momentum<\/li>\n<\/ol>\n<p>Humorous take: &#8220;Trading MDGL is like dating a brilliant scientist\u2014incredible potential but prone to dramatic mood swings. Don&#8217;t invest your heart and soul until you see consistent results!&#8221;<\/p>\n<h2>\u2705 How to Buy Madrigal Pharmaceuticals, Inc. (MDGL) Shares &#8211; Step by Step<\/h2>\n<table>\n<thead>\n<tr>\n<th>Step<\/th>\n<th>Action<\/th>\n<th>Why It Matters<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Choose a trading platform<\/td>\n<td>Ensure it offers NASDAQ access and biotech stocks<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Complete account funding<\/td>\n<td>Start with an amount you can afford to lose<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Research MDGL thoroughly<\/td>\n<td>Understand the risks and potential rewards<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>Place a limit order<\/td>\n<td>Set your maximum purchase price to avoid overpaying<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Monitor your investment<\/td>\n<td>Biotech requires active management, not set-and-forget<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Why Pocket Option Fits New Investors<\/h2>\n<p>For those looking to dip their toes into biotech investing, Pocket Option offers exceptional advantages:<\/p>\n<ul>\n<li><strong>Minimum deposit just $5<\/strong> &#8211; Test strategies with minimal risk<\/li>\n<li><strong>Lightning-fast verification<\/strong> &#8211; Single document KYC gets you trading in minutes<\/li>\n<li><strong>Diverse withdrawal options<\/strong> &#8211; Over 100 methods including crypto and e-wallets<\/li>\n<li><strong>User-friendly platform<\/strong> &#8211; Perfect for beginners navigating complex biotech stocks<\/li>\n<\/ul>\n<h2>\ud83c\udf0d Madrigal in 2025: Leading the Liver Revolution<\/h2>\n<p>Madrigal Pharmaceuticals dominates the emerging MASH treatment market with Rezdiffra, the first FDA-approved therapy for this condition affecting millions worldwide. The company&#8217;s <a href=\"https:\/\/www.stocktitan.net\/news\/MDGL\/madrigal-pharmaceuticals-reports-second-quarter-2025-financial-nfkrg4mm56mr.html\">Q2 2025 results showed spectacular growth<\/a> with $212.8 million revenue and over 23,000 patients receiving treatment.<\/p>\n<p><strong>Interesting Fact<\/strong>: In 2025, Madrigal&#8217;s headquarters became the first biotech company to install real-time liver health monitoring stations in their employee breakrooms\u2014offering free FibroScan tests to staff as part of their commitment to liver disease awareness!<\/p>\n"},"faq":[{"question":"Is MDGL stock too risky for beginners?","answer":"Yes, extremely. Biotech stocks like MDGL should represent only a small portion of a beginner's portfolio due to high volatility and regulatory risks."},{"question":"What's the biggest catalyst for MDGL price movement?","answer":"FDA and European regulatory decisions, clinical trial results, and quarterly earnings reports showing Rezdiffra adoption rates."},{"question":"How long should I hold MDGL stock?","answer":"Biotech investing requires patience\u2014think 3-5 year minimum horizon to see through clinical developments and market penetration."},{"question":"What percentage of my portfolio should be in biotech?","answer":"Most financial advisors recommend 5-10% maximum for high-risk sectors like biotech, with proper diversification."},{"question":"When is the best time to buy MDGL?","answer":"After negative news creates oversold conditions, or before major regulatory catalysts\u2014but timing biotech is notoriously difficult."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"Is MDGL stock too risky for beginners?","answer":"Yes, extremely. Biotech stocks like MDGL should represent only a small portion of a beginner's portfolio due to high volatility and regulatory risks."},{"question":"What's the biggest catalyst for MDGL price movement?","answer":"FDA and European regulatory decisions, clinical trial results, and quarterly earnings reports showing Rezdiffra adoption rates."},{"question":"How long should I hold MDGL stock?","answer":"Biotech investing requires patience\u2014think 3-5 year minimum horizon to see through clinical developments and market penetration."},{"question":"What percentage of my portfolio should be in biotech?","answer":"Most financial advisors recommend 5-10% maximum for high-risk sectors like biotech, with proper diversification."},{"question":"When is the best time to buy MDGL?","answer":"After negative news creates oversold conditions, or before major regulatory catalysts\u2014but timing biotech is notoriously difficult."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>How to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares - Investment in Madrigal Pharmaceuticals, Inc. (MDGL) stock<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"How to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares - Investment in Madrigal Pharmaceuticals, Inc. (MDGL) stock\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-20T12:08:52+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"How to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares &#8211; Investment in Madrigal Pharmaceuticals, Inc. (MDGL) stock\",\"datePublished\":\"2025-08-20T12:08:52+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\"},\"wordCount\":17,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\",\"name\":\"How to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares - Investment in Madrigal Pharmaceuticals, Inc. (MDGL) stock\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"datePublished\":\"2025-08-20T12:08:52+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"How to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares &#8211; Investment in Madrigal Pharmaceuticals, Inc. (MDGL) stock\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/en\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"How to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares - Investment in Madrigal Pharmaceuticals, Inc. (MDGL) stock","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/","og_locale":"en_US","og_type":"article","og_title":"How to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares - Investment in Madrigal Pharmaceuticals, Inc. (MDGL) stock","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-20T12:08:52+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"How to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares &#8211; Investment in Madrigal Pharmaceuticals, Inc. (MDGL) stock","datePublished":"2025-08-20T12:08:52+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"},"wordCount":17,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/","url":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/","name":"How to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares - Investment in Madrigal Pharmaceuticals, Inc. (MDGL) stock","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","datePublished":"2025-08-20T12:08:52+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals16.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/en\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/en\/"},{"@type":"ListItem","position":2,"name":"How to buy Madrigal Pharmaceuticals, Inc. (MDGL) shares &#8211; Investment in Madrigal Pharmaceuticals, Inc. (MDGL) stock"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/en\/#website","url":"https:\/\/pocketoption.com\/blog\/en\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/en\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/en\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"en_US","wpml_translations":{"fr_FR":{"locale":"fr_FR","id":340662,"slug":"how-to-buy-madrigal-pharmaceuticals","post_title":"Comment acheter des actions Madrigal Pharmaceuticals, Inc. (MDGL) - Investir dans les actions Madrigal Pharmaceuticals, Inc. (MDGL)","href":"https:\/\/pocketoption.com\/blog\/fr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"},"it_IT":{"locale":"it_IT","id":340661,"slug":"how-to-buy-madrigal-pharmaceuticals","post_title":"Come acquistare azioni Madrigal Pharmaceuticals, Inc. (MDGL) - Investire in azioni Madrigal Pharmaceuticals, Inc. (MDGL)","href":"https:\/\/pocketoption.com\/blog\/it\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"},"pl_PL":{"locale":"pl_PL","id":340665,"slug":"how-to-buy-madrigal-pharmaceuticals","post_title":"Jak kupi\u0107 akcje Madrigal Pharmaceuticals, Inc. (MDGL) - Inwestycja w akcje Madrigal Pharmaceuticals, Inc. (MDGL)","href":"https:\/\/pocketoption.com\/blog\/pl\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"},"es_ES":{"locale":"es_ES","id":340666,"slug":"how-to-buy-madrigal-pharmaceuticals","post_title":"C\u00f3mo comprar acciones de Madrigal Pharmaceuticals, Inc. (MDGL) - Inversi\u00f3n en acciones de Madrigal Pharmaceuticals, Inc. (MDGL)","href":"https:\/\/pocketoption.com\/blog\/es\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"},"th_TH":{"locale":"th_TH","id":340668,"slug":"how-to-buy-madrigal-pharmaceuticals","post_title":"\u0e27\u0e34\u0e18\u0e35\u0e0b\u0e37\u0e49\u0e2d\u0e2b\u0e38\u0e49\u0e19 Madrigal Pharmaceuticals, Inc. (MDGL) - \u0e01\u0e32\u0e23\u0e25\u0e07\u0e17\u0e38\u0e19\u0e43\u0e19\u0e2b\u0e38\u0e49\u0e19 Madrigal Pharmaceuticals, Inc. (MDGL)","href":"https:\/\/pocketoption.com\/blog\/th\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"},"tr_TR":{"locale":"tr_TR","id":340664,"slug":"how-to-buy-madrigal-pharmaceuticals","post_title":"Madrigal Pharmaceuticals, Inc. (MDGL) Hisseleri Nas\u0131l Al\u0131n\u0131r - Madrigal Pharmaceuticals, Inc. (MDGL) Hisse Senedi Yat\u0131r\u0131m\u0131","href":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"},"vt_VT":{"locale":"vt_VT","id":340663,"slug":"how-to-buy-madrigal-pharmaceuticals","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Madrigal Pharmaceuticals, Inc. (MDGL) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Madrigal Pharmaceuticals, Inc. (MDGL)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"},"pt_AA":{"locale":"pt_AA","id":340667,"slug":"how-to-buy-madrigal-pharmaceuticals","post_title":"Como comprar a\u00e7\u00f5es da Madrigal Pharmaceuticals, Inc. (MDGL) - Investimento em a\u00e7\u00f5es da Madrigal Pharmaceuticals, Inc. (MDGL)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-madrigal-pharmaceuticals\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/340622","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/comments?post=340622"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/posts\/340622\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media\/334126"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/media?parent=340622"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/categories?post=340622"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/en\/wp-json\/wp\/v2\/tags?post=340622"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}